Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 44.03 USD -0.18% Market Closed
Updated: May 18, 2024

Bristol-Myers Squibb Co
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bristol-Myers Squibb Co
Other Current Assets Peer Comparison

Comparables:
JNJ
PFE
MRK
ZTS
LLY

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Bristol-Myers Squibb Co
NYSE:BMY
Other Current Assets
$2B
CAGR 3-Years
-18%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Johnson & Johnson
NYSE:JNJ
Other Current Assets
$4.5B
CAGR 3-Years
14%
CAGR 5-Years
5%
CAGR 10-Years
-6%
Pfizer Inc
NYSE:PFE
Other Current Assets
$5.3B
CAGR 3-Years
-11%
CAGR 5-Years
-20%
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Other Current Assets
$7.2B
CAGR 3-Years
11%
CAGR 5-Years
17%
CAGR 10-Years
0%
Zoetis Inc
NYSE:ZTS
Other Current Assets
$442m
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Other Current Assets
$6.5B
CAGR 3-Years
26%
CAGR 5-Years
24%
CAGR 10-Years
19%

See Also

What is Bristol-Myers Squibb Co's Other Current Assets?
Other Current Assets
2B USD

Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Other Current Assets amounts to 2B USD.

What is Bristol-Myers Squibb Co's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-1%

Over the last year, the Other Current Assets growth was 8%. The average annual Other Current Assets growth rates for Bristol-Myers Squibb Co have been -18% over the past three years , 5% over the past five years , and -1% over the past ten years .